UPB: Upstream Bio Corp Earnings growth forecast for next year
The history of consensus earnings estimates for the coming year demonstrates current market uncertainty, where the current level equals 3.90. The Upstream Bio Inc (UPB) business model relies on antibody synthesis, which promises high margins following the R&D stage. Innovations in TSLP blocking enable the treatment of complex allergies, while a stable geopolitical backdrop ensures the uninterrupted development of science.
UPB (upstreambio.com): analytical breakdowns and indicator data
- price and consensus price forecast:
- market capitalization information:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
Debt to Equity Upstream Bio Inc|UPB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Upstream Bio|UPB - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Upstream Bio|UPB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Upstream Bio|Quick Ratio upstreambio.com
- earnings and market ratios statistics:
UPB - Net Profit|Expected Profit Upstream Bio Inc|UPB - Price to Earnings Ratio|Projected Price to Earnings Upstream Bio Inc|UPB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Upstream Bio|UPB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Upstream Bio|UPB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months upstreambio.com|UPB - Earnings per share growth rate in current year|Expected earnings per share growth for next year Upstream Bio Inc
Fundamental valuation:UPB, Upstream Bio Corp
This indicator reflects the expected earnings per share (EPS) trend, allowing for an assessment of market expectations regarding business yield growth rates in the short term. By analyzing the projected EPS vector 12 months forward, an investor gains a speculative valuation of Upstream Bio Inc. (UPB) potential, where the absence of stable cash flows makes the forecast dependent on clinical trial results and new funding rounds.
Competitor analysis for Upstream Bio Inc
Net earnings per share growth forecast for next year Argenx|Projected earnings per share growth rate for next year BNTX (BioNTech Pharma)|Earnings growth forecast for next year ABVX|ADMA - Expected net earnings per share growth next year|Protagonist - Expected earnings per share growth for next year|Earnings growth forecast for next year Immunovant Inc IMVT|KNSA - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|CLDX - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year AUPH|BCRX (BioCryst Pharmaceuticals, Inc.) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Vera Pharma (VERA)|DNTH (Dianthus Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|abcellera.com (ABCL) - Expected net earnings per share growth next year|Tourmaline Bio - Earnings growth forecast for next year|PGEN - Earnings growth forecast for next year|Pharming (PHAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Nektar Corp|Expected earnings per share growth for next year ZBIO|IMNM: Expected earnings per share trend next year|Earnings growth forecast for next year GOSS|Net earnings per share growth forecast for next year KALV (KalVista Pharma)|Earnings growth forecast for next year SEPN (Septerna Corp)|Consensus forecast of earnings per share growth for next year Pieris Corp (PVLA)|SVRA - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year rigel.com|ANAB (AnaptysBio) - Expected earnings per share growth for next year|Astria Therapeutics Inc - Expected earnings per share trend next year|ENGN (enGene Bio) - Earnings growth forecast for next year|RAPT Therapeutics Inc. (RAPT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aerovate Therapeutics Inc (JBIO)|aclaristx.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KYTX (Kyverna Therapeutics, Inc.)|TLSA - Expected earnings per share growth for next year|CABA: Expected earnings per share growth for next year|VTYX - Earnings growth forecast for next year|Theratechnologies Inc. (THTX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year AVTX (avalotx.com)|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year AGEN|Net earnings per share growth forecast for next year Climb Bio, Inc. (CLYM)|ZURA: Net earnings per share change forecast for next year|Earnings growth forecast for next year ATYR (aTyr Pharma, Inc.)|Expected earnings per share trend next year ADAG|Ikena Oncology, Inc. - Earnings growth forecast for next year|STTK - Earnings growth forecast for next year|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Connect Biopharma Holdings Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Immunic Therapeutics|Expected earnings per share growth for next year Atara Biotherapeutics Inc (ATRA)|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharmaceuticals Inc. (XFOR)|Adicet Bio, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year CELU|INmune Bio, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year barinthusbio.com BRNS|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year SAB Biotherapeutics Inc.|Net earnings per share growth forecast for next year Akari Therapeutics plc|Expected earnings per share growth for next year Enlivex Therapeutics, Ltd. (ENLV)|Expected earnings per share growth for next year QTTB (Q32 Bio Inc.)|Earnings growth forecast for next year geovax.com (GOVX)|Net earnings per share growth forecast for next year Edesa Biotech EDSA|IBIO: Projected earnings per share growth rate for next year|Carisma Tx - Earnings growth forecast for next year|Expected net earnings per share growth next year XTL Bio|BOLT (boltbio.com) - Expected earnings per share growth for next year|HCW Biologics (HCWB) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Aditxt (ADTX)|Consensus forecast of earnings per share growth for next year GRI Bio Corporation|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year HIND (reshapelifesciences.com)|REVB - Net earnings per share growth forecast for next year|Expected earnings per share trend next year INDP (Indaptus Therapeutics Inc)|SCNI: Earnings growth forecast for next year|Expected net earnings per share growth next year CalciMedica (CALI)|AFMD (Affimed NV) - Earnings growth forecast for next year|Earnings growth forecast for next year Allakos Therapeutics|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|Expected earnings per share growth for next year igmbio.com IGMS|iTeos - Expected earnings per share growth for next year|Expected earnings per share trend next year OCEA|TC Biopharm - Earnings growth forecast for next year|THRD: Net earnings per share growth forecast for next year
